Skip to content

Pilot Study for Imaging of the Esophagus Using Tethered Capsule OCT Endomicroscopy With Distal Scanning

Pilot Study for Imaging of the Esophagus Using Tethered Capsule OCT Endomicroscopy With Distal Scanning

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02947997
Enrollment
4
Registered
2016-10-28
Start date
2015-09-30
Completion date
2015-12-31
Last updated
2023-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Healthy Volunteers

Brief summary

The purpose of this study is to test feasibility of a redesigned tethered capsule catheter that contains an integrated micro-motor. Investigators will be testing imaging of this new technology in healthy volunteers.

Detailed description

10 healthy volunteers will be enrolled and asked to swallow the Distal Scanning Capsule. The subjects will be awake and un-sedated. The capsule is attached to a string like tether which allows the operator to control as well as navigate the capsule as it progresses down the esophagus using natural propulsive force called peristalsis. As the capsule progresses through the esophagus, multiple images of the esophagus are acquired in real time to be analyzed later.

Interventions

Imaging of esophagus using OFDI capsule and system

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects must be over the age of 18 * Subjects must be able to give informed consent * Subjects must have no solid food for 4 hours prior to the procedure, and only clear liquids for 2 hours prior to the procedure.

Exclusion criteria

* Subjects with the inability to swallow pills and capsules. * Esophageal fistula and/or esophageal strictures with a stricture diameter that is smaller than the diameter of the capsule. * Subjects who have a bleeding disorder and are currently on anti-coagulants.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants For Whom Good Quality Images Were Recorded After Swallowing The OFDI CapsuleApproximate 20 minute visit (5 min image acquisition)An investigator to assess the quality of the recorded images obtained with each exam after imaging has been completed

Countries

United States

Participant flow

Pre-assignment details

No significant events occurred after participants enrollment.

Participants by arm

ArmCount
OFDI Capsule Imaging
Subject will swallow the OFDI capsule and imaging will be acquired using the OFDI imaging system
4
Total4

Baseline characteristics

CharacteristicOFDI Capsule Imaging
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
4 Participants
Age, Continuous24.5 years
STANDARD_DEVIATION 5.06
Region of Enrollment
United States
4 Participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 4
serious
Total, serious adverse events
0 / 4

Outcome results

Primary

Number of Participants For Whom Good Quality Images Were Recorded After Swallowing The OFDI Capsule

An investigator to assess the quality of the recorded images obtained with each exam after imaging has been completed

Time frame: Approximate 20 minute visit (5 min image acquisition)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
OFDI Capsule ImagingNumber of Participants For Whom Good Quality Images Were Recorded After Swallowing The OFDI Capsule3 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026